Research & KnowledgeEvent: September 1, 2026
Clearmind Medicine is advancing a novel molecule with the potential to transform how we address addiction.
Published
Signal category
Research & Knowledge
Quote
“This video explores how Clearmind Medicine is advancing a novel molecule with the potential to transform how we address addiction.”
— Clearmind Medicine team
Company
Clearmind Medicine
Revolutionary Psychedelics for Treating Addiction & Mental Health
- Industry
- Biotechnology
- Location
- Vancouver, CA
- Company size
- 7 employees
Clearmind Medicine (Nasdaq: CMND) develops novel psychedelic medicines to solve widespread, yet underserved, health problems. With a strong medical management team and IP-protection, we can better the lives of millions. With a clear focus on alcohol abuse and binge drinking, Clearmind's first drug candidate addresses very common (and costly) afflictions which to date, have limited solutions.
Founded 2021